Current status and future of gene engineering in livestock

• Published in: BMB reports 2024-01, Vol.57 (1), p.50-59
• Main Authors: Dong-hyeok Kwon, Gyeong-min Gim, Soo-young Yum, Goo Jang
• Format: Article
• Language: Korean
• Subjects: CRISPR/Cas9; Engineered nuclease; Food and Drug Administration (FDA); Genetically modified organism (GMO); Livestock
• ISSN: 1976-6696; 1976-670X

The application of gene engineering in livestock is necessary for various reasons, such as increasing productivity and producing disease resistance and biomedicine models. Overall, gene engineering provides benefits to the agricultural and research aspects, and humans. In particular, productivity can be increased by producing livestock with enhanced growth and improved feed conversion efficiency. In addition, the application of the disease resistance models prevents the spread of infectious diseases, which reduces the need for treatment, such as the use of antibiotics; consequently, it promotes the overall health of the herd and reduces unexpected economic losses. The application of biomedicine could be a valuable tool for understanding specific livestock diseases and improving human welfare through the development and testing of new vaccines, research on human physiology, such as human metabolism or immune response, and research and development of xenotransplantation models. Gene engineering technology has been evolving, from random, time-consuming, and laborious methods to specific, time-saving, convenient, and stable methods. This paper reviews the overall trend of genetic engineering technologies development and their application for efficient production of genetically engineered livestock, and provides examples of technologies approved by the United States (US) Food and Drug Administration (FDA) for application in humans. [BMB Reports 2024; 57(1): 50-59]